ACIBSEARCHEAN CHEMICAL IND LTD· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 30 Jul, 2026 · 20:30 IST

Q1 FY27 results: Revenue up 13 percent, Profit after tax down 22 percent YoY

Ebitda Margin CompressionRelated Party TransactionsResults View source PDFExplain this filing

ACI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.7%Reaction day
₹559.00
prior close
₹556.00
announcement price
After-mkt
timing
Nifty Microcap 250market+1.1%-6.8% vs market
Specialty Chemicals peers, median of 94sector+0.4%-6.1% vs sector

On the reaction day the stock moved 6.8 pts less than Nifty Microcap 250 and 6.1 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.8
15m
-1.7
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.7+1.1-6.8+0.4-6.1
Next day
-4.6+2.4-7.1+1.6-6.3
2d
-5.0+2.9-7.9+1.3-6.3
3d
-6.4+4.2-10.6+1.8-8.2
4d
-7.2+4.6-11.8+2.7-9.9
5d
-9.5+4.6-14.1+2.2-11.7
1w
-8.2+4.4-12.6+3.0-11.2
15d
-11.0+5.7-16.7+2.6-13.6
1m
-13.3+6.6-19.9+4.3-17.7
2m
-12.6+5.4-18.0+2.6-15.2
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 unaudited results on July 30, 2026. Standalone revenue rose to Rs 31,593 lakhs (up 13 percent YoY), but profit after tax fell to Rs 4,053 lakhs (down 22 percent YoY) due to higher other expenses. Consolidated revenue rose to Rs 32,720 lakhs with PAT at Rs 3,035 lakhs. EPS stood at Rs 3.28 standalone and Rs 2.48 consolidated. Auditors gave an unmodified review report. Company also invested Rs 17,000 lakhs via rights issue into wholly owned subsidiary Acume Chemicals.

Likely market impact

Mixed quarter as topline growth failed to lift bottomline amid cost pressures. Watch margin trajectory and subsidiary investments.